Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis
<p><strong>Background:</strong> Previous studies had limited power to assess the associations of circulating insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) with clinically relevant prostate cancer as a primary endpoint, and the association of genetica...
Main Authors: | Watts, E, Perez-Cornago, A, Fensom, G, Noor, U, Andrews, C, Holmes, M, Allen, N, Key, T, Wrightson, R |
---|---|
Other Authors: | The PRACTICAL consortium |
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2022
|
Similar Items
-
Circulating free testosterone and risk of aggressive prostate cancer: prospective and Mendelian randomization analyses in international consortia
by: Watts, EL, et al.
Published: (2022) -
Circulating insulin‐like growth factor‐I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK Biobank
by: Watts, EL, et al.
Published: (2020) -
Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomicsResearch in context
by: Trishna A. Desai, et al.
Published: (2024-07-01) -
Physical activity in relation to circulating hormone concentrations in 117,100 men in UK Biobank
by: Watts, EL, et al.
Published: (2021) -
Circulating insulin-like growth factor-I concentrations and risk of 30 cancers: Prospective analyses in UK Biobank
by: Knuppel, A, et al.
Published: (2020)